Earnings · China A-shares
Sansure Biotech Inc. Class A (688289) earnings
Sansure Biotech Inc. Class A published its Q3 report on 2026-10-28: net profit -45.62% year on year, -63.31% excluding one-off items. Wave Radar's earnings-quality score is 90 of 100 (Sound). The stock moved -1.66% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -45.62%
- Excl. one-offs YoY
- -63.31%
- Net profit QoQ
- -87.51%
- Result
- Bad / loss
- Quality score
- 90
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.46% | — |
| 3 days | -1.66% | — |
| 7 days | +0.64% | — |
| 14 days | -5.93% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +0.80%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥104.05M | -45.62% | -63.31% | +0.66% | 0.18 | 1.47% | -1.66% | — | — |
| 2026 interim report | 2026-08-27 | ¥98.02M | -39.76% | -60.48% | -3.95% | 0.17 | 1.37% | +0.39% | +3.75% | +12.68% |
| 2026 Q1 report | 2026-04-30 | ¥49.74M | -45.78% | -45.12% | -8.02% | 0.08 | 0.69% | +0.23% | -17.45% | -19.50% |
| 2025 annual report | 2026-04-30 | ¥198.94M | -27.82% | -17.52% | +12.58% | 0.34 | 2.75% | +0.23% | -17.45% | -19.50% |
| 2025 Q3 report | 2025-10-31 | ¥191.32M | -2.10% | +3.60% | +20.49% | 0.33 | 2.63% | +2.04% | -12.70% | -8.02% |
| 2025 interim report | 2025-08-30 | ¥162.72M | +3.84% | +12.19% | +21.15% | 0.28 | 2.23% | -3.69% | -4.73% | -5.57% |
| 2025 Q1 report | 2025-04-29 | ¥91.74M | +13.22% | +22.70% | +21.62% | 0.16 | 1.26% | +7.51% | +7.29% | +4.71% |
| 2024 annual report | 2025-04-29 | ¥275.60M | -24.23% | +182.25% | +44.78% | 0.47 | 3.70% | +7.51% | +7.29% | +4.71% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.